Dallah Healthcare Co (SAU:4004) ROCE %: 6.91% (As of Mar. 2026)


SAU:4004 Dallah Healthcare Co SAU:4004
92 GF Score
Price ﷼110.00
GF Value ﷼204.73
Valuation Possible Value Trap
! 8 Warning Signs
View Full Analysis

What is Dallah Healthcare Co ROCE %?

Dallah Healthcare Co SAU:4004 -0.90% 92 ROCE % is 6.91% as of Mar. 2026. GuruFocus rates SAU:4004 with a GF Score™ of 92/100 and a GF Value™ of ﷼204.73 (Possible Value Trap). The stock has 8 warning signs investors should review.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Dallah Healthcare Co's annualized ROCE % for the quarter that ended in Mar. 2026 was 6.91%.

Dallah Healthcare Co  (SAU:4004) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Dallah Healthcare Co ROCE % Related Terms

Dallah Healthcare Co ROCE % Historical Data

* Premium members only.

The historical data trend for Dallah Healthcare Co's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Dallah Healthcare Co ROCE % Chart

Dallah Healthcare Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
ROCE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 9.35 10.30 11.07 11.75 10.83

Dallah Healthcare Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
ROCE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 12.27 9.41 9.05 9.30 6.91
SAU:4004
92GF Score
Dallah Healthcare Co SAU:4004
ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Dallah Healthcare Co ROCE % Calculation

Dallah Healthcare Co's annualized ROCE % for the fiscal year that ended in Dec. 2025 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=697.123/( ( (6611.6 - 1304.353) + (9135.304 - 1570.623) )/ 2 )
=697.123/( (5307.247+7564.681)/ 2 )
=697.123/6435.964
=10.83 %

Dallah Healthcare Co's ROCE % of for the quarter that ended in Mar. 2026 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Mar. 2026 )  (Q: Dec. 2025 )(Q: Mar. 2026 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Mar. 2026 )  (Q: Dec. 2025 )(Q: Mar. 2026 )
=525.016/( ( (9135.304 - 1570.623) + (9312.097 - 1679.79) )/ 2 )
=525.016/( ( 7564.681 + 7632.307 )/ 2 )
=525.016/7598.494
=6.91 %

(1) Note: The EBIT data used here is four times the quarterly (Mar. 2026) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROCE % →
What does a ROCE % of 6.91% mean?
Dallah Healthcare Co (SAU:4004) has a ROCE % of 6.91% as of Mar. 2026.
Is Dallah Healthcare Co's ROCE % too high?
Dallah Healthcare Co's current ROCE % is 6.91%. The Healthcare Providers & Services industry median ROCE % is 6.43. Dallah Healthcare Co's value of 6.91% is 7.5% above this industry median. Overall, Dallah Healthcare Co has a GF Score™ of 92/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Dallah Healthcare Co's ROCE % compare to HCA and THC?
Dallah Healthcare Co's ROCE % of 6.91% can be compared against companies in the Healthcare Providers & Services industry. The industry median ROCE % is 6.43. Dallah Healthcare Co's value of 6.91% is 7.5% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for a Healthcare Providers & Services company?
The median ROCE % among Healthcare Providers & Services companies is 6.43, based on 645 companies in the industry. Companies in the top quartile (top 25%) have a ROCE % significantly above this median, while those in the bottom quartile fall well below. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Dallah Healthcare Co's current ROCE % of 6.91% is 7.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. For the Healthcare Providers & Services industry, the median ROCE % is 6.43 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Dallah Healthcare Co's current ROCE % is 6.91%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Dallah Healthcare Co stock overvalued right now?
Based on GuruFocus' analysis, Dallah Healthcare Co (SAU:4004) is currently considered Possible Value Trap. The stock's GF Value™ is ﷼204.73, compared to a current price of ﷼110.00 — trading 46.3% below its estimated fair value. The current ROCE % is 6.91% and 7.5% above the Healthcare Providers & Services industry median of 6.43. Dallah Healthcare Co's overall GF Score™ is 92/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For Dallah Healthcare Co (SAU:4004), the current ROCE % is 6.91% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Dallah Healthcare Co (SAU:4004) Overvalued in 2026?

Based on GuruFocus' analysis, Dallah Healthcare Co stock appears to be undervalued. The current stock price of ﷼110.00 is trading 46.3% below its estimated GF Value™ of ﷼204.73. GuruFocus considers Dallah Healthcare Co to be Possible Value Trap.

Key valuation signals for SAU:4004:

  • ROCE %: 6.91%
  • GF Value™: ﷼204.73 vs. price of ﷼110.00 (46.3% below fair value)
  • GF Score™: 92/100 with 8 warning signs
  • Industry Position: 7.5% above the Healthcare Providers & Services median

No single metric tells the full story. See the SAU:4004 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Dallah Healthcare Co Business Description

Address 1157 King Fahad Road, Nakheel building, 2nd Floor, Riyadh, SAU, 12381
Dallah Healthcare Co provides and operates healthcare programs and utilities in the Kingdom of Saudi Arabia. The objectives of the company include operating, managing, and maintaining the healthcare entities, wholesale medicines, and retail of medical and surgical equipment, prosthetics, and devices for the disabled, hospital equipment, and manufacturing medicines, pharmaceuticals, herbals, health, cosmetics, detergents, disinfectants, and packaging in the Kingdom of Saudi Arabia. The reportable segments of the company are Medical Facilities and Pharmacies, and Distribution of Pharmaceutical Products. The company generates the majority of its revenue from the Medical Facilities and Pharmacies segment.
92GF Score

Get the complete analysis for SAU:4004

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

﷼110.00
Price
﷼204.73
GF Value